Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's Wednesday bro most flippers get out after 3 days
Hmm let's see how high she a go
Someone's taking a few.
Not arguing there. You get into penny stocks u know it's a high risk gamble. If you can't handle that don't get involved in it.
All penny stocks are scams it's like playing the lotto good luck.
He always does
By next month this one will go high.
Yea flippers adding to it.
2s a be up today
Most have been set up to get out that's waited along time. It's their loss
Only 1.7 left it a go
HCTI starting to flare up.
Knocking on close to half a billion in volume I'd say it's getting ready to move north.
Wrong post guys forget my last. Lol
At close to half a billion in volume I'd say it's getting attention.
This is last news I got idk
Hybrid Receives Follow on Order from Major Partner
3/2/17, 8:32 AM
SAN FRANCISCO, March 02, 2017 (GLOBE NEWSWIRE) -- Hybrid Coating Technologies Inc. (OTC Pink:HCTI) is pleased to announce that it has received a follow on order for its non-isocyanate binder from PPG-Comex for its erasable coating product. “We are very pleased to receive this follow on order as we continue to increase our presence in the Mexican market,” said Joseph Kristul President and CEO, “This demonstrates the market’s interest in our technology as we continue to penetrate different segments of the market across multiple geographic territories.”
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of Hybrid Coating Technologies Inc. to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, and other risks. Hybrid Coating Technologies Inc undertakes no duty to update any forward-looking statement(s) and/or to confirm the statement(s) to actual results or changes in Hybrid Coating Technologies Inc. expectations.
About Hybrid Coating TechnologiesHybrid Coating Technologies (HCT) is a San Francisco-based innovator focused on improving the quality and safety of foams, coatings, and adhesives for industrial and commercial customers around the world. We are the exclusive licensee of Green Polyurethane™ foam, coatings, and adhesives – the world’s first-ever patent protected polyurethane-based foam, coatings, and adhesive products that eliminate toxic isocyanates from the entire production process (licensed by Nanotech Industries, Inc.) and the 2015 recipient of the Presidential Green Chemistry Award.
The Problem of Conventional Foams/Coatings/Paint and IsocyanatesConventional polyurethane (PU) paint and coatings have many disadvantages: they are porous, permeable and maintain poor hydrolytic stability. This makes the material highly vulnerable to environmental degradation and ultimately leads to their chemical decomposition, especially when in contact with water. Conventional PU foams such as spray foam insulation are applied via a spraying mechanism that sends toxic isocyanates in the air – exposing workers to the dangers of toxic isocyanates. Strict and costly health & safety measures have to be implemented in the manufacture and application of conventional polyurethane due to the toxicity of isocyanates. This is why regulatory bodies around the world are now looking toward phasing out the use of isocyanates.
The Green Polyurethane™ SolutionGreen Polyurethane™ (also referred to as “HNIPU” - hybrid non-isocyanate polyurethane) is a “hybrid” material that combines the high chemical resistance properties of epoxy and advanced durability and wear resistance properties of polyurethane, making it the perfect coating application for sanitary, high traffic and corrosive surface areas. As a hybrid material with superior properties, Green Polyurethane ™ can be applied in one or two coatings, providing a welcome cost-saving substitute to currently used multi-layered coating applications. Its safety features allow it to be applied without the interruption of business due to public exposure, creating an additional 30-60% savings on application costs for customers. As a foam, Green Polyurethane™ provides high R values up to 6.0, energy savings up to 30% and improved tensile strength over conventional foam without using dangerous isocyanates.
Recent Anti-Isocyanate Regulatory PressureUS EPA MDI Action Plan: The US EPA (Environmental Protection Agency) is taking progressive action to regulate and potentially ban isocyanates and has mentioned Hybrid’s technology as an alternative to toxic polyurethane in its MDI Action Plan against isocyanates (see page 4 Figovsky and Shapovalov). http://www.epa.gov/sites/production/files/2015-09/documents/tdi.pdf
OSHA National Emphasis Program: On June 25, 2013 the Occupational Safety and Health Administration (OSHA), a division of the US Department of Labor, initiated a National Emphasis Program to protect workers from the serious health effects from occupational exposure to isocyanates. Isocyanates are found in polyurethane based products. According to OSHA, "Workers exposed to isocyanates can suffer debilitating health problems for months or even years after exposure which could result in death."
California’s Department of Toxic Substances Control (DTSC) on March 13, 2014 selected isocyanates and two others substances from a list of 1,100 toxic components that it will focus on with the goal of potentially banning them altogether within the next two years. The announcement is part of a bigger effort to educate consumers and manufacturers about product safety under the Green-Chemistry Law, which went into effect in California last year. Under the law, the agency has jurisdiction to ban these products altogether after following proper protocol. That process includes workshops, a public comment period and requiring manufacturers that want to sell these products in California to determine whether it would be feasible to use safer ingredients.
The US EPA on January 8, 2015 announced that it was taking action to protect consumers from new uses and imports of harmful isocyanates in polyurethane. The EPA’s proposed action, a Significant New Use Rule (SNUR) under the Toxic Substances Control Act (TSCA), would require manufacturers (including importers) to notify the EPA at least 90 days before starting or resuming new uses of isocyanates in polyurethane based consumer products. The EPA would then have the opportunity to evaluate the intended use of and if necessary, to take action to prohibit or limit all products containing over one tenth of one percent of the chemical including imported products that make their way into the United States.
Public Relations and Media Contact:
Everest Corporate Advisors Inc.
Jack Thompson
www.everestcorp.net
702-902-2361
Source: Hybrid
This is last bit of news I've gotten
Healthcare Commits and Announces Acquisition
2/23/17, 4:00 AM
Orange, CA, Feb. 23, 2017 (GLOBE NEWSWIRE) -- Supurva Healthcare Group, Inc. (OTC PINK: SPRV), Giorgio Johnson, Interim CEO and President of Supurva Healthcare Group, Inc. is pleased to announce that the Company has agreed to acquire a net revenue interest (the Transaction”), in a Medical Cannabis dispensary with a private Canadian company located in British Columbia. The dispensary has an estimated capital cost of $200,000.00 and is projected to be operational within 60 days of the Closing of the Transaction.
“We are pleased to have been offered this investment opportunity which will provide significant and near term revenue to the Company. We are seeing a steady stream of projects in this rapidly expanding market and will continue to add skilled personnel in the required areas as we continue to acquire and develop opportunities.
SUMMARY OF INDICATIVE TERMS AND CONDITIONS
As currently contemplated, the Transaction is expected to have the terms and conditions summarized below. The terms and conditions are summary in nature and are subject to supplement or amendment prior to the closing of the Transaction upon mutual agreement and will be documented in mutually acceptable transaction documents on the closing date (the “Transaction Documents”).
Senior Secured Debenture. Supurva will be
Investment: Structure: issued a debenture secured by a senior
charge over the current and post-Closing
assets of the Dispensary.
Principle: Two Hundred Thousand Dollars ($200,000) US
Dollars.
The principle amount of the debenture,
Term: calculated after the payment of the coupon,
shall be 24 months from the Closing Date.
Coupon Rate: Twelve Percent (12%) per annum.
Before the principle amount of the Debenture
Before Payout Net Revenue Interest: is repaid Supurva shall own an 80% net
revenue interest in the Dispensary.
After the principle amount of the Debenture
After Payout Net Revenue Interest: is repaid Supurva shall own a 49% net
revenue interest in the Dispensary.
Closing Date: Closing of the Transaction is expected to
occur on the 31st day of March 2017.
Closing is conditioned upon satisfaction of
certain conditions to be set forth in the
Conditions precedent to Closing: Transaction Documents. The Conditions to
closing will be customary for a transaction
of this nature, including Supurva obtaining
credit and other internal approvals.
The Transaction will be evidenced by the
Senior Debenture Agreement. Additional
Transaction Documents mutually satisfactory
to the parties may be required. Any credit
Documentation: documentation shall contain representations,
warranties, affirmative and negative
covenants and events of default customary
for Transactions of this type and other
terms deemed appropriate by Supurva.
Governing Law: State of Delaware
About Supurva Healthcare Group, Inc.
Supurva Healthcare Group, Inc., a Delaware Corporation, is a healthcare holdings company based in Orange, California.
Forward Looking Statement
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks. Supurva Healthcare Group, Inc. is a healthcare holdings company. At the time of this release Supurva Healthcare Group, Inc. lacks the financial capabilities to meet its financial obligations and its management expects to dilute the company's shares to raise the necessary operating capital. Based upon industry standards Supurva would be considered highly speculative and lacks any competitive advantage over its competition. Additional risks you should consider are that this list is limited and additional risk not mentioned may apply: failure to meet Supurva's financial and contractual obligations, Supurva's managerial errors made based upon the Company's limited experience and knowledge of the industry, acts of God and regulatory risk. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements
Giorgio Johnson, Interim CEO/President
Supurva Healthcare Group, Inc.
giorgio@reignccgroup.com
Source: Supurva Healthcare Group, I
SPRV is starting to come alive
Ill buy in some see what happens.
Sorry I don't argue with bashers bro good luck on finding u one that a argue with you.
Yea mad cause u sold your shares before waiting on it I see.
Figure that a be next week.
4s a be up today watch
It a move it's getting ready to.
Not strange someone either gave out something coming or setting it up for a pump and dump. It's a gamble either way in penny land.
I've never seen a flipper flip at .0001 for no profit nice try.
Agree there.
Stocks starting to hit this one a be hitting soon.
.01+ on the way
And u wonder why buyers get ran off selling to much to early.
What I did bought in and waited for a alert to go off. We gonna do good here
We try to tell everyone to be patient lol.
Yes we could
Hmm. Looks like something brewing thanks for that chart.
Where's that chart? Was no volume at all today.
I may be wrong but....I think this stock is getting ready to run some.
Everything's in red. Where do u see any buys at. You color blind? All sells no buys.
People been trying to get out that's why ask was stacked.
900k on ones left